MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.	https://doi.org/10.1158/0008-5472.CAN-08-4025	2009	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Low miR-210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia.	https://doi.org/10.3892/ol.2017.7229	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA profiling in pediatric acute lymphoblastic leukemia: novel prognostic tools	https://doi.org/10.3109/10428194.2012.685731	2012	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
Genome-wide analysis of small RNA and novel MicroRNA discovery in human acute lymphoblastic leukemia based on extensive sequencing approach.	https://doi.org/10.1371/journal.pone.0006849	2009	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia.	https://doi.org/10.1016/j.gene.2017.07.052	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment	https://doi.org/10.1038/bjc.2017.256	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
The Hedgehog signal transducer Smoothened and microRNA-326: pathogenesis and regulation of drug resistance in pediatric B-cell acute lymphoblastic leukemia.	https://doi.org/10.2147/CMAR.S214405	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA-31 is a potential biomarker for screening B-lymphoblastic leukemia in children.	https://doi.org/10.3892/ol.2019.10843	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles	https://doi.org/10.1002/ijc.25436	2010	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma	https://doi.org/10.1038/bjc.2011.388	2011	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican	https://doi.org/10.1007/s00381-014-2416-5	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.	https://doi.org/10.3727/096368914X678364	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis	https://doi.org/10.1002/gcc.22189	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Extensive miRNA expression analysis in craniopharyngiomas.	https://doi.org//10.1007/s00381-016-3131-1	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study	https://doi.org/10.3390/cancers11101476	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Differential Expression of microRNAs in Medulloblastoma and the Potential Functional Consequences.	https://doi.org/10.5137/1019-5149.JTN.19379-16.2	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 4 Master/Detail View
A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy	https://doi.org/10.1007/s00432-017-2478-3	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications